Home Cart Sign in  
Chemical Structure| 163680-77-1 Chemical Structure| 163680-77-1

Structure of Pazufloxacin Mesylate
CAS No.: 163680-77-1

Chemical Structure| 163680-77-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Pazufloxacin Mesylate is a fluoroquinolone antibiotic working by inhibiting both DNA gyrase and topoisomerase IV.

Synonyms: T-3762; Pazufloxacin methanesulfonate; Pazufloxacin (mesylate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Pazufloxacin Mesylate

CAS No. :163680-77-1
Formula : C17H19FN2O7S
M.W : 414.41
SMILES Code : O=C(C1=CN2C3=C(C=C(F)C(C4(N)CC4)=C3OC[C@@H]2C)C1=O)O.CS(=O)(O)=O
Synonyms :
T-3762; Pazufloxacin methanesulfonate; Pazufloxacin (mesylate)
MDL No. :MFCD00913262
InChI Key :UDHGFPATQWQARM-FJXQXJEOSA-N
Pubchem ID :6918232

Safety of Pazufloxacin Mesylate

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Pseudomonas aeruginosa ATCC 27853 0.12, 0.25, 0.5, 0.75, or 1 µg/mL 16–20 h To determine the minimum inhibitory concentration (MIC) of Pazufloxacin against Pseudomonas aeruginosa PMC9312304
E. coli UTI89 50 μM 7 days Evaluate the killing effect of Pazufloxacin on E. coli UTI89 persisters, results showed complete eradication of persisters after 7 days of drug exposure PMC4790332

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice Neutropenic thigh infection model Subcutaneous injection 2.5, 10, and 40 mg/kg Single dose To evaluate the in vivo pharmacokinetic/pharmacodynamic (PK/PD) parameters of Pazufloxacin against Pseudomonas aeruginosa infection PMC9312304
Soviet Chinchilla rabbits Healthy adult male rabbits Oral 10 mg/kg Every 12 hours for 21 days To evaluate the effect of pazufloxacin and meloxicam on antioxidant status and oxidative stress in rabbits. Results showed that pazufloxacin and meloxicam, either alone or in combination, caused significant lipid peroxidation and alterations in antioxidant parameters. PMC4113241

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.41mL

0.48mL

0.24mL

12.07mL

2.41mL

1.21mL

24.13mL

4.83mL

2.41mL

References

 

Historical Records

Categories